Abstract
Roux-en-Y gastric bypass (RYGB) is a mainstay of management of morbid obesity, particularly in individuals with significant weight-related medical comorbidities, but it also represents an effective therapeutic option for select patients with gastroesophageal reflux disease (GERD). The purpose of this chapter is to describe the appropriate population that may benefit from RYGB as management of GERD, specific surgical techniques for the performance of REYGB, perioperative management, and management of special situations and postoperative complications.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Reference
Barr AC, et al. GERD and acid reduction medication use following gastric bypass and sleeve gastrectomy. Surg Endosc. 2017;31:410–5.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 SAGES
About this chapter
Cite this chapter
Dong, M., Herron, D.M. (2019). Laparoscopic Anti-reflux Surgery: Laparoscopic Roux-en-Y Gastric Bypass. In: Grams, J., Perry, K., Tavakkoli, A. (eds) The SAGES Manual of Foregut Surgery . Springer, Cham. https://doi.org/10.1007/978-3-319-96122-4_14
Download citation
DOI: https://doi.org/10.1007/978-3-319-96122-4_14
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-96121-7
Online ISBN: 978-3-319-96122-4
eBook Packages: MedicineMedicine (R0)